Steven Mintz, Director at Serina Therapeutics, Inc. (SER), bought 15,802 shares at $0.10 ($92K) on 2024-05-21, disclosed to the SEC on 2024-05-23.
Open-market purchase of $92k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.10 | 6,651 | $665 | 0.7% |
| 2 | $9.75 | 2,500 | $24K | 26.6% |
| 3 | $10.00 | 6,651 | $67K | 72.6% |
| Total | $5.79 avg | 15,802 | $92K | 100% |
| Filing → |
| SER | BUY | 2024-06-27 | $71K | — | Filing → |
| SER | BUY | 2024-05-23 | $121K | — | Filing → |